STRENSIQ, created in 2013 (United States), from 585 sister brands and 17478 competing brands. The STRENSIQ brand is owned by ASTRAZENECA, a company listed in London. The International Securities Identification Number (ISIN) of ASTRAZENECA is GB0009895292. STRENSIQ belongs to the Drug Manufacturers business sector.